Fundz

Td Tx Inc. reported raising $8.35 Million in an initial SEC Form D filing, from an offering of $8.35 Million

PRIVATENov 05, 2019

Amount Raised

$8.35 Million

$8.35 Million sold, per SEC Form D (first sale Nov 5, 2019)

Round Type

Venture

WalthamOtherBiotechnologyHealth Careresearch

Quick answer

Affinia Therapeutics raised $8.35 Million in a funding round, dated November 5, 2019. Affinia Therapeutics is based in Waltham, Massachusetts, United States.

How much did Affinia Therapeutics raise?
Affinia Therapeutics raised $8.35 Million in a funding round on November 5, 2019.
What does Affinia Therapeutics do?
Affinia Therapeutics is pioneering a shift to a new class of rationally designed gene therapies that treat rare and prevalent diseases.
Where is Affinia Therapeutics based and how big is it?
Affinia Therapeutics is based in Waltham, Massachusetts, United States. Fundz records about 49 employees.
Who are the decision-makers at Affinia Therapeutics?
Fundz holds 2 contacts at Affinia Therapeutics, including the Chief Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in research and Biotechnology around the same time

Companies in the same sectors as Affinia Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Grail raised $125M on December 12, 2019.
  • Climb Bio, Inc. raised $10M on October 23, 2019.
  • NOWDiagnostics, Inc. raised $19M on December 20, 2019.
  • Sycamore Biopharma raised $500K (Seed) on December 20, 2019.
  • ENDRA Life Sciences raised $8.6M on December 20, 2019.
  • BIODESIX INC raised $3M (Seed) on December 20, 2019.

Who to call at Affinia Therapeutics, and when

A new round usually means Affinia Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Affinia Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Affinia Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Affinia Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Affinia Therapeutics

Location

43 Foundry Ave

Waltham, Massachusetts, United States

About

Affinia Therapeutics is pioneering a shift to a new class of rationally designed gene therapies that treat rare and prevalent diseases. Affinia Therapeutics’ pipeline of first-in-class or best-in-class product candidates in cardiovascular and neurological diseases leverages its proprietary next-generation capsids, payloads, or manufacturing approaches and have shown efficacy, safety, and differentiation in relevant animal models.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Affinia Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsRick M., Chief Executive Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Affinia Therapeutics's next move

See what Strategic adds

Affinia Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.